tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

BCDA Stock Latest News

BioCardia Regains Full Compliance with Nasdaq Listing Requirements
Press ReleasesBioCardia Regains Full Compliance with Nasdaq Listing Requirements
2d ago
BCDA
BioCardia regains full compliance with Nasdaq listing rules
PremiumThe Fly
BioCardia regains full compliance with Nasdaq listing rules
2d ago
BCDA
BioCardia Announces Closing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules
PremiumPress Releases
BioCardia Announces Closing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules
10d ago
BCDA
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
21d ago
BCDA
MNKD
BioCardia Announces Pricing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules
PremiumPress Releases
BioCardia Announces Pricing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules
21d ago
BCDA
BioCardia prices 2.4M shares at $3.00 in upsized public offering
PremiumThe FlyBioCardia prices 2.4M shares at $3.00 in upsized public offering
21d ago
BCDA
BioCardia Announces FDA Market Clearance of Morph® DNA™ Steerable Introducer Product Family
Premium
Press Releases
BioCardia Announces FDA Market Clearance of Morph® DNA™ Steerable Introducer Product Family
22d ago
BCDA
BioCardia announces FDA market clearance of Morph DNA Steerable Introducer
Premium
The Fly
BioCardia announces FDA market clearance of Morph DNA Steerable Introducer
22d ago
BCDA
BioCardia Expands Treatment in Heart Failure Trial
PremiumCompany Announcements
BioCardia Expands Treatment in Heart Failure Trial
30d ago
8K
BCDA
BioCardia announces FDA approved amendment for CardiAMP trial
PremiumThe Fly
BioCardia announces FDA approved amendment for CardiAMP trial
30d ago
BCDA
FDA Approves CardiAMP® Heart Failure II Protocol Amendment to Use Proprietary Cell Population Analysis Screening to Define Treatment
PremiumPress Releases
FDA Approves CardiAMP® Heart Failure II Protocol Amendment to Use Proprietary Cell Population Analysis Screening to Define Treatment
30d ago
BCDA
BioCardia price target adjusted to $25 from $4 at H.C. Wainwright
PremiumThe Fly
BioCardia price target adjusted to $25 from $4 at H.C. Wainwright
1M ago
BCDA
BioCardia Reports Second Quarter 2024 Business Highlights and Financial Results
PremiumPress ReleasesBioCardia Reports Second Quarter 2024 Business Highlights and Financial Results
1M ago
BCDA
BioCardia submits for FDA approval of Morph DNA Steerable Introducer family
Premium
The Fly
BioCardia submits for FDA approval of Morph DNA Steerable Introducer family
2M ago
BCDA
BioCardia Initiates Phase III Trial for Heart Failure Treatment
Premium
Company Announcements
BioCardia Initiates Phase III Trial for Heart Failure Treatment
2M ago
8K
BCDA
BioCardia announces confirmatory Phase 3 trial of CardiAMP commenced enrollment
PremiumThe Fly
BioCardia announces confirmatory Phase 3 trial of CardiAMP commenced enrollment
2M ago
BCDA
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
ABIO
ALLO
BioCardia Announces United States Patent Issuance on Morph DNA Multi-Directional Steerable Catheter Transseptal Application
PremiumPress Releases
BioCardia Announces United States Patent Issuance on Morph DNA Multi-Directional Steerable Catheter Transseptal Application
2M ago
BCDA
BioCardia announces US Patent Office granted patent on Morph DNA
PremiumThe Fly
BioCardia announces US Patent Office granted patent on Morph DNA
2M ago
BCDA
BioCardia’s ProtheraCytes Phase II Success Promises Future Growth
PremiumCompany AnnouncementsBioCardia’s ProtheraCytes Phase II Success Promises Future Growth
2M ago
8K
BCDA
BioCardia, CellProthera collaborate on Phase II trial of ProtheraCytes
Premium
The Fly
BioCardia, CellProthera collaborate on Phase II trial of ProtheraCytes
2M ago
BCDA
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
BCDA
GERN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >